Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Avidan U Neumann

Therapeutic Response to Peg-Ifn-Alpha-2b and Ribavirin in HIV/HCV Co-Infected African-American and Caucasian Patients as a Function of HCV Viral Kinetics and Interferon Pharmacodynamics

AIDS

English

Changes in Anti-Viral Effectiveness of Interferon After Dose Reduction in Chronic Hepatitis C Patients: A Case Control Study

English

Related publications

Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV Co-Infected Patients: Implications for Treatment Outcomes

Journal of Hepatology

Hepatology

2010

English

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

Journal of Acquired Immune Deficiency Syndromes

Infectious Diseases

Pharmacology

2009

English

Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin

Alimentary Pharmacology and Therapeutics

English

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Journal of Medical Virology

Virology

Infectious Diseases

2012

English

An Hepatitis C Virus (HCV)/HIV Co-Infected Patient Who Developed Severe Hepatitis During Chronic HCV Infection: Sustained Viral Response With Simeprevir Plus Peginterferon-Alpha and Ribavirin

Internal Medicine

Medicine

2015

English

Influence of HCV Genotype 1 Subtypes on the Virus Response to PEG Interferon Alpha-2a Plus Ribavirin Therapy

Journal of Medical Virology

Virology

Infectious Diseases

2011

English

Changes of Body Immunity and Inflammatory Response in HIV/HCV Co-Infected Patients

Experimental and Therapeutic Medicine

English

Mixed Treatment Comparisons to Compare Simeprevir With Boceprevir and Telaprevir in Combination With Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected With Genotype 1 Hepatitis C Virus (Hcv)

English

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Avidan U Neumann

Therapeutic Response to Peg-Ifn-Alpha-2b and Ribavirin in HIV/HCV Co-Infected African-American and Caucasian Patients as a Function of HCV Viral Kinetics and Interferon Pharmacodynamics

Changes in Anti-Viral Effectiveness of Interferon After Dose Reduction in Chronic Hepatitis C Patients: A Case Control Study

Related publications

Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV Co-Infected Patients: Implications for Treatment Outcomes

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

An Hepatitis C Virus (HCV)/HIV Co-Infected Patient Who Developed Severe Hepatitis During Chronic HCV Infection: Sustained Viral Response With Simeprevir Plus Peginterferon-Alpha and Ribavirin

Influence of HCV Genotype 1 Subtypes on the Virus Response to PEG Interferon Alpha-2a Plus Ribavirin Therapy

Changes of Body Immunity and Inflammatory Response in HIV/HCV Co-Infected Patients

Mixed Treatment Comparisons to Compare Simeprevir With Boceprevir and Telaprevir in Combination With Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected With Genotype 1 Hepatitis C Virus (Hcv)

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure